Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: A case report

被引:5
作者
Macchia, G [1 ]
Costamagna, G
Morganti, AG
Mutignani, M
Giuliante, F
Clemente, G
Deodato, F
Smaniotto, D
Mattiucci, GC
Sallustio, G
Valentini, V
Nuzzo, G
Cellini, N
机构
[1] Catholic Univ, Dept Radiat Therapy, Campobasso, Italy
[2] Catholic Univ, Dept Radiol, Campobasso, Italy
[3] Catholic Univ, Dept Radiat Therapy, Rome, Italy
[4] Catholic Univ, Dept Surg Digest Endoscopy, Rome, Italy
[5] Catholic Univ, Dept Surg, Rome, Italy
关键词
biliary papillary neoplasms; brachytherapy; 192-iridium; papillary cholangiocarcinoma;
D O I
10.1016/j.dld.2004.07.022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A 46-year-old female patient, with mild cholestasis by a large papillary cholangiocarcinoma involving the left hepatic duct, received intralummal brachytherapy (50 Gy at 1 cm from the source axis) with the aim to relieve biliary obstruction without stent positioning. The patient presented with haemobilia and vegetant lesions in the left main biliary duct, and thus she had a high risk of early stent obstruction. Eighteen months after the treatment the patient presented tumour progression in the controlateral hepatic lobe, but had a patent left hepatic duct, without signs of cholestasis and/or cholangitis. Based on this and other published reports, intralummal brachytherapy may be tested in a setting different from standard setting with the aim to safely palliate jaundice in patients with intraductal tumour growth in the biliary tract. (C) 2005 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:615 / 618
页数:4
相关论文
共 12 条
[1]
A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma [J].
Bowling, TE ;
Galbraith, SM ;
Hatfield, ARW ;
Solano, J ;
Spittle, MF .
GUT, 1996, 39 (06) :852-855
[2]
CONROY RM, 1982, CANCER, V49, P1321, DOI 10.1002/1097-0142(19820401)49:7<1321::AID-CNCR2820490702>3.0.CO
[3]
2-S
[4]
Malignant biliary duct obstruction: Long-term experience with Gianturco stents and combined-modality radiation therapy [J].
Eschelman, DJ ;
Shapiro, MJ ;
Bonn, J ;
Sullivan, KL ;
Alden, ME ;
Hovsepian, DM ;
Gardiner, GA .
RADIOLOGY, 1996, 200 (03) :717-724
[5]
External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma [J].
Foo, ML ;
Gunderson, LL ;
Bender, CE ;
Buskirk, SJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (04) :929-935
[6]
Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma [J].
González, DG ;
Gouma, DJ ;
Rauws, EAJ ;
van Gulik, TM ;
Bosma, A ;
Koedooder, C .
ANNALS OF ONCOLOGY, 1999, 10 :215-220
[7]
Gunvén P, 2000, CANCER-AM CANCER SOC, V89, P69, DOI 10.1002/1097-0142(20000701)89:1<69::AID-CNCR10>3.0.CO
[8]
2-9
[9]
Kubota Y, 1998, HEPATO-GASTROENTEROL, V45, P415
[10]
Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: Is it just for palliation? [J].
Montemaggi, P ;
Morganti, AG ;
Dobelbower, RR ;
Brizi, G ;
Smaniotto, D ;
Costamagna, G ;
Cellini, N ;
Marano, P .
RADIOLOGY, 1996, 199 (03) :861-866